Single-dose effects of isosorbide mononitrate alone or in combination with losartan on central blood pressure

Journal of the American Society of Hypertension

Volumn 4, Issue 6, 2010, Pages 311-318

  Kaufman, Rhonda ^a   Nunes, Irene ^a   Bolognese, James A ^a   Miller, Deborah L ^a   Salotti, Dennis ^a   McCarthy, Jennifer M ^a   Smith, William B ^b   Herman, Gary A ^a   Feig, Peter U ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Angiotensin receptor blocker; Augmentation index; Central blood pressure; Hypertension; Nitric oxide

Indexed keywords

ISOSORBIDE MONONITRATE; LOSARTAN; NITRIC OXIDE;

ADULT; AGED; ARTICLE; AUGMENTATION INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEADACHE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE DRUG DOSE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; ISOSORBIDE DINITRATE; LOSARTAN; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; PREHYPERTENSION;

EID: 78649977261     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.10.004     Document Type: Article

References (24)

1. M.F. O'Rourke, and J.B. Seward Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov Mayo Clin Proc 81 2006 1057 1068
2. L.D. Greig, S.J. Leslie, F.W. Gibb, S. Tan, D.E. Newby, and D.J. Webb Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index Br J Clin Pharmacol 59 2005 265 270
3. G.S. Stokes, E.S. Barin, and K.L. Gilfillan Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension Hypertension 41 2003 297 301
4. E. Agabiti-Rosei, G. Mancia, M.F. O'Rourke, M.J. Roman, M.E. Safar, and H. Smulyan Central blood pressure measurements and antihypertensive therapy: a consensus document Hypertension 50 2007 154 160
5. J.A. Chirinos, J.P. Zambrano, S. Chakko, A. Veerani, A. Schob, and H.J. Willens Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease Hypertension 45 2005 980 985
6. C.M. McEniery, Yasmin, B. McDonnell, M. Munnery, S.M. Wallace, and C.V. Rowe Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II Hypertension 51 2008 1476 1482
7. M.J. Roman, R.B. Devereux, J.R. Kizer, E.T. Lee, J.M. Galloway, and T. Ali Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study Hypertension 50 2007 197 203
8. M.E. Safar, J. Blacher, B. Pannier, A.P. Guerin, S.J. Marchais, and P.M. Guyonvarch Central pulse pressure and mortality in end-stage renal disease Hypertension 39 2002 735 738
9. R. Pini, M.C. Cavallini, V. Palmieri, N. Marchionni, M. Di Bari, and R.B. Devereux Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study J Am Coll Cardiol 51 2008 2432 2439
10. C.M. McEniery, Yasmin, I.R. Hall, A. Qasem, I.B. Wilkinson, and J.R. Cockcroft ACCT Investigators. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT) J Am Coll Cardiol 46 2005 1753 1760
11. B. Williams, P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, and D. Collier CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
12. D.M. Lloyd-Jones, J.C. Evans, and D. Levy Hypertension in adults across the age spectrum: current outcomes and control in the community JAMA 294 2005 466 472
13. P. Forte, M. Copland, L.M. Smith, E. Milne, J. Sutherland, and N. Benjamin Basal nitric oxide synthesis in essential hypertension Lancet 349 1997 837 842
14. S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Vitamin C improves endothelium-dependent vasodilatation by restoring nitric oxide activity in essential hypertension Circulation 97 1998 2222 2229
15. M.J.F. Starmans-Kool, H.A.J. Kleinjans, F.A.T. Lustermans, J.A. Dragten, J.S. Breed, and L.M.A.B. Van Bortel Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule J Hum Hypertens 12 1998 557 561
16. G.S. Stokes, A.J. Bune, N. Huon, and E.S. Barin Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension Hypertension 45 2005 380 384
17. K. Nithipatikom, B.B. Holmes, M.J. McCoy, C.J. Hillard, and W.B. Campbell Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells Am J Physiol Endocrinol Metab 287 2004 E820 E827
18. M.F. O'Rourke Time domain analysis of the arterial pulse in clinical medicine Med Bio Eng Comput 47 2009 119 129
19. B. Williams, P.S. Lacy for the CAFE and the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators. Impact of heart rate on central aortic pressures and hemodynamics Analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate J Am Coll Cardiol 75 2009 705 713
20. A. Mahmud, and J. Feely Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition Am J Hypertens 15 2002 321 325
21. J. Davies, E. Carr, M. Band, A. Morris, and A. Struthers Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters? J Renin Angiotensin Aldosterone Syst 6 2005 151 153
22. L.J. Ignarro, C. Napoli, and J. Loscalzo Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview Circ Res 90 2002 21 28
23. W.W. Nichols Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms Am J Hypertens 18 2005 3S 10S
24. T. Morgan, J. Lauri, D. Bertram, and A. Anderson Effect of different antihypertensive drug classes on central aortic pressure Am J Hypertens 17 2004 118 123